Diskussion zur BICO Group Aktie WKN: A2PX00 ISIN: SE0013647385 Forum: Aktien User: Hedgehog3

Wie meinst Du das??

Vor vier Wochen ging auch bis auf 14 EK. Das bleibt so. Ab dem dritten Quartal wird noch mal genauer geschaut.

@MePredator Wieviele Stücke haste nun insgesamt beisammen?

Na ja wenn Du mit jeder Woche ein bisschen Verlust zufrieden bist ,ist ja auch gut. Jeder wie er mag. 😬

Im Vergleich zu meisten anderen Aktien, ist diese heute nicht großartig ins Minus gedreht.

Bis dann 🫡

Meine letzte Tranche wird jetzt die nächsten Minuten greifen. Dann habe ich meinen EK von 45 Euro endgültig auf meinen Wunsch EK von 15 Euro gesenkt. Jetzt wird nichts mehr nachgekauft Und in 1-2 Jahren wieder rein geguckt.

Na wenn das schon gut läuft, dann will ich nicht sehen wenn es schlecht läuft. 😂

Sieht ja diese Woche gar nicht so übel aus... Mal sehen was noch so geht.

Ich finde die Kombination der vielen kleinen innovativen Firmen in dem großen BICO-Netzwerk echt unglaublich spannend! BICO wird seinen Weg machen, wenn das Konzept von Implementierung und Abstoßung von Unternehmen so konsequent weitergeführt wird!

BICO Group’s business area Bioautomation is expanding its manufacturing product offering by introducing The Nucleus™ Automation Ecosystem, a fully integrated platform bringing a new level of modularity, flexibility and scalability to the manufacturing market. Designed with the support of industry leader ABB Robotics, The Nucleus™ reduces time and costs by a seamless transition from R&D through to manufacturing, due to unique modularity while utilizing knowledge and validation though the scale up phases. The first prototype will be showcased at SLAS International Conference and Exhibition (February 24th- March 1st), as a part of the SCIENION`s sciFLEXARRAYER manufacturing solutions. Supporting the complete application envelope, The Nucleus™ utilizes core precise material handling – regardless of the substrate type, dedicated environmental control specific to process steps, through to pick and place and packaging. Process steps include, but are not limited to, RFID readouts, quality control stations, cloud storage, laser welding, drying, and pouching operations. The Nucleus™ ensures precise motion control and real-time analysis, including individual tracing of devices. Additionally, the process steps are housed in the same enclosure, thus reducing the overall footprint of the system, as well as facility utilities for the manufacturing space. Coupled with SCIENION’s precision dispense technologies enables a platform to deliver a dynamic dispense range from picoliter to nanoliter volumes in a fully controlled environment. Dr. Holger Eickhoff, Co-founder and Co-CEO of SCIENION, said “We are delighted to expand our manufacturing solutions to the marketplace with proven suppliers. We have seen a dynamic increase in our customers’ scale up requirements, and The Nucleus™ allows us to support the entire application from precise material handling, environmental control specific to each step, through to packaging. Moreover, this will give our customer access to the ABB Robotics service and support Worldwide”. Erik Gatenholm, President & CEO of BICO Group, "With the all-new Nucleus™ platform, our Bioautomation Business Area will continue to support our current customers while also transition into new market opportunities such as printing and manufacturing of medical devices, approaching higher end market segments and add value where the highest level of precision dispensing and automation is needed" About SCIENION SCIENION, a BICO company, is a renowned specialist in ultra-low volume precision liquid handling in the pico-liter to micro-liter range, enabling applications from research to high-throughput production of assays in diagnostics and life sciences. Addressing the dynamically increasing needs for miniaturization and multiplex analyses, SCIENION is an ISO 9001:2015 certified complete solution provider offering a unique portfolio of automated precision dispensing systems, readers, consumables, assay development and contract manufacturing services. www.scienion.com About ABB ABB Robotics & Discrete Automation as one of the world’s leading robotics and machine automation suppliers, is the only company with a comprehensive and integrated portfolio covering robots, Autonomous Mobile Robots and machine automation solutions, designed and orchestrated by our value-creating software. We help companies of all sizes and sectors - from automotive to electronics and logistics – become more resilient, flexible and efficient. ABB Robotics & Discrete Automation supports customers in the transition towards the connected and collaborative factory of the future. The business area employs approximately 11,000 people at over 100 locations in approximately 53 countries.

Biosero zählt erst ab dem kommenden Quartal als organisch, weils dann 12 Monate zu BICO gehört. Das organische Wachstum war dieses Quartal so miserabel, weil Ginolis im Q4 2021 brutale Umsätze gemacht und und im letzten Quartal eingebrochen ist mit gerade mal 9 Mio SEK.

Steht glaub ich auch irgendwo das biosero nicht berücksichtigt worden ist

Exciting news! We have teamed up with Nanyang Technological University Singapore to open the doors to a new lab focusing on bioprinting for regenerative medicine and drug discovery. Our collaboration will explore topics like developing effective blood-brain models, bone tissue engineering, and biofabrication of vascularised skin for in vitro studies and, eventually, in vivo application. We are thrilled to witness bioprinting becoming more accessible to scientists and driving innovation to pave the way for breakthroughs in life-saving treatments. Paulo Bartolo Learn more https://bit.ly/3KBZBSo

Dann muss beim organischen Wachstum Biosero nicht berücksichtigt worden sein, da das Unternehmen ja nachweislich gewachsen… sind ja auch in Dollar Allzeithochumsätze